Clinical and prognostic significance of HIF-1?, PTEN, CD44v6, and survivin for gastric cancer: a meta-analysis.

ABSTRACT:

Purpose

This study was to quantitatively summarize published data for evaluating the clinical and prognostic significance of four proteins involved in hypoxia-inducible factor-1 (HIF-1?) regulation of the metastasis cascade.

Methods

Searches were performed using the MEDLINE, EMBASE, Cochrane Library, and Chinese Biomedicine databases without any language restrictions. Studies were pooled and either the summary risk ratio (RR) or odds ratio (OR) was calculated. Potential sources of heterogeneity were sought out via subgroup and sensitivity analyses, and publication bias was also performed.

Results

Seventeen studies evaluated HIF-1?, 20 studies evaluated phosphatase and tensin homolog (PTEN), 20 studies evaluated Survivin, and 16 studies evaluated CD44v6. Our results showed that increased HIF-1? expression was linked to a poor 5-year overall survival (RR?=?1.508; 95% confidence interval (CI) 1.318-1.725; P<0.001). Decreased survival was heavily influenced by advanced tumor invasion (OR?=?3.050; 95% CI 2.067-4.501; P<0.001), lymph node metastasis (1415 patients; OR?=?3.486, 95% CI 2.737-4.440; P<0.001), distant metastasis (OR?=?6.635; 95% CI 1.855-23.738; P?=?0.004), vascular invasion (OR?=?2.368; 95% CI 1.725-3.252; P<0.001), dedifferentiation (OR?=?2.112; 95% CI 1.410-3.163; P<0.001), tumor size (OR?=?1.921; 95% CI 1.395-2.647; P<0.001), and a higher TNM stage (OR?=? 2.762; 95% CI 1.941-3.942; P<0.001). Similarly, aberrant expression of PTEN, CD44v6, and Survivin were also observed in tumors that correlated with poor OS. The higher ORs of death at 5 years were 1.637 (95% CI?=?1.452-1.845; P<0.001), 1.901 (95% CI?=?1.432-2.525; P<0.001), and 1.627 (95% CI?=?1.384-1.913; P<0.001), respectively, with an OR>2 for the main stratified meta-analyses of clinical factors.

Conclusions

Our findings indicate that HIF-1?/PTEN/CD44v6/Survivin, as measured by immunohistochemistry, can be used to predict the prognosis and potential for invasion and metastasis in Asian patients with gastric cancer. The development of strategies against this subset of proteins could lead to new therapeutic approaches.

SUBMITTER: Chen J 

PROVIDER: S-EPMC3960154 | biostudies-literature | 2014

REPOSITORIES: biostudies-literature